Company
Organon & Co. (OGN)
Standardized SEC financial data for Organon & Co. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001821825 · NYSE · Pharmaceutical Preparations.
Gross margin
53.3%
Net margin
3.0%
Revenue growth (YoY)
-2.9%
Return on equity
24.9%
Free cash flow
$538.0M
Debt / equity
11.49×
Current ratio
1.82×
EPS (diluted)
$0.72
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | $6.30B | $6.17B | $6.26B | $6.40B | $6.22B |
| Cost of revenue |
Balance sheet
| USD | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | — | $737.0M | $706.0M | $693.0M | $675.0M | $574.0M |
| Inventory |
Cash flow
| USD | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | — | $2.16B | $858.0M | $799.0M | $939.0M | $700.0M |
| Capital expenditures |
Get OGN data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/OGN/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/OGN/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"